Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02100904

Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
578 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
Female
Age
21 Years
Healthy volunteers
Accepted

Summary

The ULTRA Registry is a nationwide observational arm of the ULTRA trial. Data from the ULTRA Registry will be used to evaluate the long-term safety and efficacy of laparoscopic RF ablation (Acessa). The ULTRA Registry will recruit women age 21 or older who plan to undergo or have undergone laparoscopic RF ablation (Acessa) or myomectomy within the United States. Participants will be recruited through study materials distributed at clinical offices across the country where gynecologists are performing laparoscopic RF ablation (Acessa). Study participants will consent to participate in a 3 year prospective study conducted by UCSF but the fibroid procedure will be performed by the study participants' own gynecologist. We will evaluate changes in fibroid-related symptoms from pre-treatment values to 6, 12, 18, 24, 30, and 36 months after RFA (Acessa). We will determine long-term efficacy of RFA (Acessa) by evaluating the rate of re-treatment for symptomatic fibroids after the RFA (Acessa) procedure versus myomectomy. Participants will be asked for permission to review their medical records to assess surgical and pregnancy outcomes. UC San Francisco will have oversight of all scientific and administrative aspects of the study. All study data will be stored securely in a HIPAA compliant, secure database monitored by the UC San Francisco Coordinating Center.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency ablation of fibroids
PROCEDUREMyomectomy of fibroids

Timeline

Start date
2014-05-01
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2014-04-01
Last updated
2026-03-11

Locations

12 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02100904. Inclusion in this directory is not an endorsement.